HCA Healthcare stock (US40412C1018): acquisition of Medac urgent care clinics and valuation metrics in focus

HCA Healthcare shares on the NYSE traded around the mid-USD 360 range on 06/05/2026, while the company expanded its US footprint by acquiring Medac Urgent Care clinics in North Carolina. Investors are also watching updated earnings guidance and valuation metrics for the S&P 500 health care provider.

HCA Healthcare shares on the New York Stock Exchange traded at USD 362.27 on 06/05/2026, with the stock fractionally lower on the day, according to MarketBeat data as of 06/05/2026 (MarketBeat as of 06/05/2026). As a major US hospital operator listed on the NYSE under the ticker HCA and based in Nashville, United States, the group remains closely watched by investors for both its operational expansion and earnings power.

On the strategic front, HCA Healthcare has moved to deepen its regional presence in the United States by acquiring five Medac Urgent Care locations in the Wilmington, North Carolina area and an additional 12 urgent care sites in surrounding regions, according to a report published on 06/05/2026 by Greater Wilmington Business Journal (Greater Wilmington Business Journal as of 06/05/2026). The move underscores the companys continued focus on outpatient and urgent care services alongside its core hospital portfolio.

In addition to these network expansion steps, HCA Healthcare has communicated earnings expectations for the current financial period. The company has set its FY 2026 earnings per share guidance in a range of USD 29.10 to USD 31.50, according to figures cited by MarketBeat on 06/05/2026, with the same source noting that the average analyst forecast for the year stands at USD 30.07 per share as of that date. This guidance range places investor attention squarely on the companys ability to sustain margins and volume across its United States and United Kingdom operations in a still-evolving healthcare environment.

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: HCA Healthcare
• Sector/industry: Health care services / hospital operators
• Headquarters/country: Nashville, United States
• Core markets: United States and United Kingdom
• Key revenue drivers: Acute care hospitals, outpatient and ambulatory services, emergency and urgent care, and related clinical services
• Home exchange/listing venue: New York Stock Exchange (HCA)
• Trading currency: USD

HCA Healthcare: core business model

HCA Healthcare operates a large network of acute care hospitals and outpatient centers, generating most of its revenue from patient services across inpatient, ambulatory, emergency, and urgent care settings in the United States and the United Kingdom.

Valuation metrics and multiples for HCA Healthcare

With HCA Healthcare shares quoted at USD 362.27 on the NYSE on 06/05/2026, investors can use the companys stated FY 2026 earnings per share guidance range of USD 29.10 to USD 31.50 to derive an indicative price-to-earnings band, implying a forward multiple in the low- to mid-teens based on MarketBeat data as of 06/05/2026. Using the midpoint of the EPS guidance range at USD 30.30, that share price corresponds to a forward P/E of roughly 12 times at the time of the quote, highlighting how the market is valuing the companys earnings prospects in the current cycle.

According to MarketBeat on 06/05/2026, analysts on average expect HCA Healthcare to deliver EPS of USD 30.07 for FY 2026, which is close to the center of the companys own guidance corridor and provides a further reference point for assessing valuation relative to consensus expectations. In parallel, MarketBeat data as of the same date indicates that the stock carried an average rating of Moderate Buy and an average analyst price target around USD 506.14, suggesting that sell-side models embed expectations for earnings growth and continued capital deployment, even though individual ratings and targets can diverge significantly by institution. Dividend yield and EV/EBITDA metrics are not specified in these sources for the exact date but are typically incorporated by investors when comparing HCA Healthcare with other S&P 500 health care providers.

Conclusion

HCA Healthcare is trading in the mid-USD 360s on the NYSE as of 06/05/2026, while managements FY 2026 EPS guidance range and consensus forecasts give investors a framework for evaluating the companys earnings power and implied valuation multiples. The acquisition of Medac Urgent Care clinics in North Carolina adds incremental outpatient and urgent care capacity, fitting with the broader strategy of strengthening HCA Healthcares regional networks in its home United States market. Against that backdrop, the balance between organic operating trends, portfolio expansion, and the valuation suggested by current guidance and analyst estimates is likely to remain central to how the stock is assessed.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.